Purdue’s Pill Success Is Bad News for Zogenix Zohydro, ZGNX Stock

Purdue Pharma's plans to pursue FDA approval of its back-pain medication could mean the end of a Zogenix drug, sending ZGNX stock plunging. More 

IDIX: Idenix Pharmaceuticals Up 17% on No News

Indenix Pharmaceuticals stock shot up in pre-market trading on Monday, but IDIX shares cooled significantly in morning trading on a lack of news. More 

DRUG ALERT: Pfizer Issues Nationwide Recall of Effexor Antidepressant

Pfizer has announced a voluntary recall for its antidepressant drug after a bottle was found to contain the wrong drug. More 

PBYI: Why Puma Biotechnology Shares Are Soaring

Puma Biotechnology said last week that European regulators had affirmed a key patent, sending PBYI stock surging. More 

Healthcare Stocks: No Longer a Sure Thing

Healthcare stocks have outperformed in recent years, but investors need to be selective with valuations that now are at richer levels. More 

ACCL Stock – Accelrys Shares Skyrocket on Dassault Deal

France's Dassault says it will purchased Accelrys for $12.50 a share, sending ACCL stock jumping almost 29%. More 

TXMD Stock – TherapeuticsMD Shares Surge on Vaginal Study Results

TherapeuticsMD said that two studies found positive results for its new Vulvar Vaginal Atrophy drug, sending TXMD stock up in Tuesday trading. More